What is the price of generic cabergoline on the market?

Cabergoline is a prescription drug commonly used to treat hyperprolactinemia (HPRL), pituitary prolactinoma and other related diseases. It belongs to the dopamine receptor agonist class of drugs. The drug can inhibit the excessive secretion of prolactin from the pituitary gland by selectively activating D2 receptors, thereby improving patients' clinical manifestations such as menstrual disorders, infertility, galactorrhea or sexual dysfunction caused by elevated prolactin. However, currently in mainland China, neither the original drug nor the domestic generic version of cabergoline has been officially approved for marketing. Therefore, domestic patients cannot directly purchase the drug in hospitals and pharmacies, and there is no clear domestic reference standard for its price.

In addition to the original drug, some overseas pharmaceutical companies currently produce generic cabergoline drugs. The more common one is the generic cabergoline drug produced by Lucius Pharmaceuticals in Laos. The specification is 0.5mg*8 tablets. Each box sells for about more than 100 yuan. This type of generic drug is consistent with the original drug in terms of drug ingredients, dosage and therapeutic effects, and has been verified by bioequivalence studies, so it also has reliable clinical efficacy and safety. Some patients will choose to obtain such generic drugs through cross-border medical channels or overseas purchasing agents to reduce the economic burden of long-term medication.

Whether they are original drugs or generic drugs, they are all prescription drugs. Patients should not buy them by themselves or change drugs at will, but should use them under the guidance of a doctor. Since cabergoline may cause certain adverse reactions during the course of taking it, such as nausea, headache, hypotension, palpitations, etc., and may even cause the risk of fibrosis in a few cases, strict medication monitoring and individualized dosage adjustment are very important. After long-term medication, some patients' prolactin levels return to normal, their tumors shrink, or their symptoms improve significantly. Doctors may consider gradually reducing the dose or even discontinuing the medication, which all need to be formulated in conjunction with professional evaluation.

Reference materials:https://www.drugs.com/mtm/cabergoline.html